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Abstract
Periodontal disease destroys the tooth-supporting tissues as a result of chronic inflammation elicited by
bacterial accumulation on tooth surfaces. Porphyromonas gingivalis is a major periodontal pathogen,
with a significant capacity to perturb connective tissue homeostasis and immune responses in the
periodontium, attributed to its virulence factors, including a group of secreted cysteine proteases
(gingipains). PAR-2 (protease-activated receptor-2) is a G-protein-coupled receptor activated upon
proteolytic cleavage, mediating intracellular signalling events related to infection and inflammation,
such as cytokine production. GF (gingival fibroblasts) and T cells have central roles in periodontal
inflammation, which can potentially be mediated by PAR-2. The aims of this study were to investigate
the effects of P. gingivalis on PAR-2 gene expression in human GF and Jurkat T cells, using quantitative
real-time PCR, and to evaluate the involvement of gingipains. After 6 h of challenge with ascending
concentrations of P. gingivalis, PAR-2 expression was up-regulated in both cell types by approximately
5-fold, compared with the control. The P. gingivalis concentration required for maximal PAR-2
induction was 4-fold greater in GF than Jurkat T cells. Heat inactivation or chemical inhibition of
cysteine proteases abolished the capacity of P. gingivalis to induce PAR-2 expression in Jurkat T cells.
In conclusion, P. gingivalis can induce PAR-2 expression in GF and Jurkat T cells, potentially attributed
to its gingipains. These findings denote that P. gingivalis may perturb the host immune and
inflammatory responses by enhancing PAR-2 expression, thus contributing to the pathogenesis of
periodontal disease.
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Abstract 
Periodontal disease destroys the tooth-supporting tissues as a result of chronic 
inflammation elicited by bacterial accumulation on tooth surfaces. Porphyromonas 
gingivalis is a major periodontal pathogen, with a significant capacity to perturb 
connective tissue homeostasis and immune responses in the periodontium, attributed 
to its virulence factors, including a group of secreted cysteine proteiases (gingipains). 
Protease-activated receptor (PAR)-2 is a G-protein-coupled receptor activated upon 
proteolytic cleavage, mediating intracellular signaling events related to infection and 
inflammation, such as cytokine production. Gingival fibroblasts (GF) and T-cells have 
central roles in periodontal inflammation, which can potentially be mediated by PAR-
2. The aims of this study were to investigate the effects of P. gingivalis on PAR-2 
gene expression in human GF and Jurkat T-cells, using quantitative real-time PCR, 
and to evaluate the involvement of gingipains. After 6 h of challenge with ascending 
concentrations of P. gingivalis, PAR-2 expression was up-regulated in both cell types 
by approximately 5-fold, compared to the control. The P. gingivalis concentration 
required for maximal PAR-2 induction was 4-fold greater in GF than Jurkat T-cells. 
Heat-inactivation or chemical inhibition of cysteine proteases abolished the capacity 
of P. gingivalis to induce PAR-2 expression in Jurkat T-cells. In conclusion, P. 
gingivalis can induce PAR-2 expression in GF and Jurkat T-cells, potentially 
attributed to its gingipains. These findings denote that P. gingivalis may perturb the 
host immune and inflammatory responses by enhancing PAR-2 expression, thus 
contributing to the pathogenesis of periodontal disease. 
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1. Introduction 
Periodontitis is an infectious disease that destroys the tooth-supporting (periodontal) 
tissues as a result of chronic inflammation caused by bacterial accumulation on tooth 
surfaces. It is relatively common in the human population and if left untreated, it may 
result in tooth loss and subsequently impaired function of mastication and poor 
aesthetics. The bacterial challenge triggers several complex responses in the resident 
periodontal tissues, as well as the local cells of the immune system, which can be 
highly variable among individuals (Schenkein, 2006). The equilibrium between 
bacteria and host response is the determinant factor, as its disturbance can eventually 
lead to the destruction of the periodontal connective tissue and supporting alveolar 
bone, culminating in tooth loss. The host response essentially manifests as a series of 
inflammatory events that can lead to periodontitis, if excessive (Kornman et al., 1997, 
Schenkein, 2006). On the histopathological level, the inflammatory responses involve 
both structural cells of the periodontium, such as the gingival fibroblasts (GF), as well 
as local cells of the immune system, such as T-cells (Page and Schroeder, 1976). It is 
now well established that T-cells are a major cell population implicated in the 
pathogenesis of periodontal diseases, particularly mediating alveolar bone destruction 
(Taubman and Kawai, 2001). 
Porphyromonas gingivalis is a gram-negative black pigmenting anaerobe, 
reported to be a major member of the pathogenic microbiota, particularly in chronic 
periodontitis (Zambon et al., 1981, Slots et al., 1986, Holt et al., 1999, Yilmaz, 2008). 
Despite the profound inflammatory response, the host immune system is usually not 
able to eliminate P. gingivalis infection. This bacterial species may therefore have the 
potential to perturb the normal immune and inflammatory host responses, permitting 
its colonization and propagation in the oral cavity (Lamont and Jenkinson, 1998). 
These capacities are attributed to its virulence factors, including its lipopolysaccharide 
(LPS) (Bainbridge et al., 2002) and gingipains (Curtis et al., 2001). The gingipains in 
particular are a group of cysteine protease enzymes, believed to be main 
endopeptidases produced by the bacterium (Kesavalu et al., 1997), as they represent 
the majority of the outer surface protein on P. gingivalis W50 (Veith et al., 2002). 
These are mainly the Arg-X and the Lys-X gingipains (Curtis et al., 2001). Clinical 
studies show that P. gingivalis infection leads to elevated serum IgG antibody 
response to the gingipains, in as many as 92% of patients with chronic periodontitis 
(O'Brien-Simpson et al., 2000). Due to their enzymatic activity, they are considered 
major virulence factors for periodontal tissue matrix degradation and evasion of host 
defences. They are reported to degrade the CD14 (Sugawara et al., 2000) and TLR 
(Kishimoto et al., 2006) receptors on monocytes, as well as pro-inflammatory 
cytokines, such as TNF-α, IL-1, IL-6 and IL-8 (Calkins et al., 1998, Banbula et al., 
1999, Baba et al., 2002, Kobayashi-Sakamoto et al., 2003), immunoglobulins 
(Gregory et al., 1992), and plasma host protease inhibitors (Grenier, 1996).  
Protease-activated receptors (PARs) are a family of G-protein-coupled 
receptors that mediate a cascade of intracellular signaling events related to injury, 
infection, inflammation and cell death (Coelho et al., 2003, Ossovskaya and Bunnett, 
2004). Their activation depends on proteolytic cleavage of the extracellular N-
terminal domain, resulting in .the generation of a new “tethered ligand” N-terminal, 
which can autoactivate the cell. Up to date, four members of the PAR family have 
been cloned. PAR-1, PAR-3 and PAR-4 can be activated by thrombin, whereas PAR-
2 can be activated by several proteases, including cysteine proteases (Lourbakos et al., 
1998, Abraham et al., 2000, Vergnolle et al., 2001b). PAR-2 is expressed by virtually 
all cell types, including epithelial and endothelial cells, fibroblasts, osteoblasts, 
neutrophils, myocytes, neurons, T-cells and astrocytes (Nystedt et al., 1996, Abraham 
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et al., 2000, Uehara et al., 2002, Uehara et al., 2003). It is involved in several 
pathophysiological processes, such as leukocyte migration, cytokine production, 
inflammation of the joints, skin and kidney, hyperalgesia, allergic inflammation of 
airways, and periodontal disease (Vergnolle et al., 2001a, Ossovskaya and Bunnett, 
2004, Holzhausen et al., 2005b). 
It is hypothesised that P. gingivalis challenge would induce PAR-2 expression 
in gingival connective tissue cells, as well as cells of the immune system. Since PAR-
2 can be activated by cysteine proteases, it is also postulated that P. gingivalis 
gingipains could be involved in the induction of PAR-2 expression. Therefore, the 
primary aim of the present in vitro study was to investigate the effects of P. gingivalis 
challenge on PAR-2 gene expression in human GF and a human T-cell line. A further 
aim was to investigate if gingipains are involved the regulation of PAR-2 expression 
by P. gingivalis. 
 
 
2. Materials and Methods 
 
2.1 Human GF cell cultures 
Human GF cell lines were established as previously described (Belibasakis et al., 
2005, Belibasakis et al., 2007). Briefly, the gingival tissue biopsies used were 
obtained from four healthy young individuals (ages, 13 to 16 years), who were about 
to have their first premolars removed in the course of orthodontic treatment. Ethical 
approval was granted by the Human Studies Ethical Committee of Umeå University, 
Sweden, and informed consent was given by all subjects. The obtained cell lines were 
cultured in Minimum Essential Medium (MEM) Alpha (Gibco BRL Life 
Technologies, UK), supplemented with 10 % heat-inactivated foetal bovine serum 
(Bio-Whittaker, Maryland, USA), 50 U/ml penicillin, and 50 µg/ml streptomycin 
(Gibco BRL Life Technologies, UK). All cell lines were confirmed to be free of 
mycoplasma infections by DAPI fluorescence staining. For the experiments, GF 
cultures cells at passages 3 or 4, were seeded at concentration 20 x 103 cells/cm2, and 
allowed to attach for 24 h, maintaining a sub-confluent status. Thereafter, the cells 
were cultured for 6 h in presence or absence of P. gingivalis bacterial culture 
supernatants at sub-toxic concentrations, as previously defined (Belibasakis et al., 
2007) 
 
2.2 Jurkat T-cell cultures 
The Jurkat T-lymphocyte leukemia cell line (E6-1; American Type Tissue Culture 
Collection) was cultured as previously described (Bostanci et al., 2009). Briefly, the 
cells were maintained in RPMI Glutamax culture medium (Gibco BRL Life 
Technologies, UK), which was supplemented with 10% FBS. The cells were 
harvested and plated in 12-well tissue culture plates, at density 106 cells/well, in 1 ml 
culture media. Thereafter, the cells were cultured for 6 h in presence or absence of P. 
gingivalis bacterial culture supernatants at sub-toxic concentrations, as previously 
defined (Bostanci et al., 2009). 
 
2.3 Bacteria and growth conditions  
Porphyromonas gingivalis W50 wild-type strain expressing both Arg-X gingipain A 
and Arg-X gingipain B (rgpA rgpB), as well as Lys-X gingipain (kgp), was used in 
this study. This bacterial strain was cultured in blood agar base supplemented with 5% 
horse blood (Oxoid, Hampshire, UK) and maintained by weekly subculture for up to 5 
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weeks. Liquid cultures were prepared by inoculation of bacterial colonies (3-4 days 
old) from blood agar plates into 10 ml brain heart infusion (BHI) broth (Oxoid, 
Hampshire, UK) supplemented with 5 mg/liter haemin (Sigma, Dorset, UK), and 
incubated for 24 h. A 10% inoculum was transferred to 90 ml of the same medium 
and incubated for 6 days. All cultures were grown at 37°C in a Don Whitley 
anaerobic cabinet, MACS MG500, in an atmosphere of 80% N2, 10% H2, and 10% 
CO2. After this culture period, bacteria were harvested by centrifugation at 10.000 x g 
for 15 min at 4˚C and the supernatants were collected, filter-sterilized over a 0.2 µm 
filter, and stored at -80˚C until further use. For the experiments, this P. gingivalis 
preparation was diluted in the cell culture medium and its concentration was 
expressed as total bacterial protein (µg/ml) present in the cell cultures. Protein 
concentration was determined by Bio-Rad Protein assay (Bio-Rad, Hertfordshire, UK) 
according to the manufacturer’s instructions. 
 
2.4 Inhibition of cysteine protease activity in P. gingivalis 
To investigate the role of P. gingivalis cysteine proteases (gingipains) in PAR-2 
mRNA expression by Jurkat T-cells, P. gingivalis W50 culture supernatant was pre-
treated with 1 mM of the cysteine protease inhibitor Na-p-tosyl-lysine chloromethyl 
ketone hydrochloride (TLCK) (Sigma-Aldrich, Dorset, UK) for 1 h at 4˚C, prior to 
addition to the cell cultures. The effects of this TLCK-treated P. gingivalis 
preparation were compared to the ones elicited by the un-treated P. gingivalis. To 
investigate the role of proteinaceous components in general, P. gingivalis W50 culture 
supernatant was heat-treated at 70°C for 1 h, prior to addition to the cell cultures. 
 
2.5 RNA extraction  
Upon termination of the experiments, the culture media were discarded and the cells 
were washed twice in PBS before being treated with RLT lysis buffer (QIAGEN, 
Crawley, UK). The collected cell lysate was homogenized with QIAshredder 
(QIAGEN, Crawley, UK) and total RNA was extracted by the RNeasy Mini Kit 
(QIAGEN, Crawley, UK), according to the manufacturer’s instructions. The extracted 
RNA was finally eluted in 40 µl RNase free water. The RNA concentration of the 
samples was determined in a NanoDrop spectrophotometer, by measuring the 
absorbance at 260 nm (A260). 
 
2.6 cDNA synthesis 
One µg of total RNA was reverse transcribed into single-stranded cDNA by using M-
MLV Reverse Transcriptase (RNase H Minus, Point Mutant), Oligo(dT)15 Primers, 
and PCR Nucleotide (dNTPs) Mix, in a final volume of 15 µl, according to the 
manufacturer’s protocol (all from Promega, Southampton, UK). The samples and 
master mix were heated at 40°C for 60 min, and 70°C for 15 min, followed by cooling 
down at 6°C and fast-spin centrifugation. The resulting cDNA was stored at -20°C 
until further use. 
 
2.7 Quantitative TaqMan® real-time PCR 
For PAR-2 gene expression analysis, quantitative TaqMan® real-time PCR was 
performed in an ABI Prism 7900HT Sequence Detection System and software 
(Applied Biosystems, Foster City, CA). 18S rRNA was used as an endogenous RNA 
control in the samples. The probes and the primers were synthesized by Applied 
Biosystems (TaqMan® Gene Exression Assay IDs PAR-2: Hs00173741-m1 and 18S 
rRNA: Hs99999901-s1) and the amplification reactions were performed with qPCR 
Master Mix (Abgene, Epsom, UK). The standard PCR conditions were 10 min at 
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95ºC, followed 40 cycles at 95ºC for 15 seconds and 60ºC for 1 min. The expression 
levels of PAR-2 transcripts were calculated by using the comparative Cycle threshold 
(Ct) method (2-∆Ct formula) after normalization to 18S rRNA. 
 
2.8 Statistical analysis 
The significance of differences between the various groups was assessed by one-way 
analysis of variance (ANOVA) and Bonferroni post-hoc test. P values < 0.05 were 
considered indicative of statistical significance. The data are expressed as mean ± 
standard error of mean (SEM).  
 
 
3. Results 
 
3.1 Effect of P. gingivalis on PAR-2 expression in human GF 
The effect of P. gingivalis on PAR-2 mRNA expression was evaluated by quantitative 
real-time PCR in human GF cultures. PAR-2 expression was detected in the 
unchallenged cells (control). After 6 h of bacterial challenge with ascending 
concentrations of P. gingivalis, a concentration-dependent up-regulation of PAR-2 
mRNA expression was observed. This expression peaked with 12.5 µg/ml P. 
gingivalis, but decreased again with the highest (25 µg/ml) concentration used (Figure 
1). Compared to the control, up-regulation of PAR-2 mRNA expression proved to be 
statistically significant by challenge with 6.25 µg/ml and 12.5 µg/ml P. gingivalis 
protein (4-fold and 5.6-fold, respectively). The scale of the relative PAR-2 mRNA 
expression was at the range of 10-7 to 10-6 in these cells. 
 
3.2 Effect of P. gingivalis on PAR-2 expression in T-cells 
The effect of P. gingivalis on PAR-2 mRNA expression was also investigated in 
Jurkat T-cell cultures. Compared to the unchallenged control, P. gingivalis 
significantly enhanced PAR-2 mRNA expression, peaking with 3.25 µg/ml, but 
decreased with the highest (6.25 µg/ml) P. gingivalis concentration used (Figure 2). 
Nevertheless, only 3.125 µg/ml P. gingivalis caused a significant up-regulation of 
PAR-2 mRNA expression, compared to the control (4.8-fold). The scale of relative 
PAR-2 expression was at the range of 10-4 to 10-3 in these cells 
 
3.3 Involvement of P. gingivalis cysteine proteinases 
The involvement of P. gingivalis cysteine proteinases in the observed regulation of 
PAR-2 mRNA expression was also investigated. For this purpose, P. gingivalis 
culture supernatants (3.125 µg/ml) were heat-inactivated or TLCK-treated prior to 
challenging Jurkat T-cell cultures, in order to destroy the proteinaceous components, 
or inhibit the cysteine protease activity, respectively. After 6 h of challenge, both 
treatments resulted in abolishment of PAR-2 mRNA expression to control levels 
(Figure 3), which proved to be statistically significant compared to the un-treated P. 
gingivalis-challenged group. No statistically significant differences were observed 
between the control and the heat-inactivated or TLCK-treated groups (P>0.05), 
indicating that the responsible component for PAR-2 regulation is potentially 
proteinaceous and proteolytic. 
 
4. Discussion 
The present study investigated PAR-2 mRNA expression in human GF and Jurkat T-
cells, with particular focus on the regulation of this expression by P. gingivalis. Under 
physiological conditions it was found that PAR-2 is expressed by both cell types, 
 6 
although the expression level in T-cells is greater than in fibroblasts. Previous studies 
have reported that PAR-2 is expressed under physiological conditions in a number of 
cell types, including osteoblasts (Abraham et al., 2000), oral epithelial cells 
(Lourbakos et al., 2001a), human GF (Uehara et al., 2003), platelets (Lourbakos et al., 
2001b), neutrophils (Lourbakos et al., 1998), neurons (Vergnolle et al., 2001), T-cells 
(Fiorucci et al., 2001), dental pulp cells (Tancharoen et al., 2005), sperm cells and 
oocytes (Smith et al., 2000). Nevertheless, there is no comparative evidence on 
quantitative differences of PAR-2 expression between cell types. The present study 
demonstrates that the basal level of PAR-2 expression in T-cells is greater than that in 
GF, indicating that PAR-2 may have distinct physiological roles, depending on the 
cell lineage. To this extent, PAR-2 is suggested to play multiple physiological and 
pathological processes, in various tissues, organs and systems (Fiorucci et al., 2001, 
Ossovskaya and Bunnett, 2004). In the case of inflammation, PAR-2 activation is 
shown to induce the production of the pro-inflammatory cytokines IL-1, IL-6 and IL-
8 (Lourbakos et al., 2001, Uehara et al., 2008b, Giacaman et al., 2009). 
Further on, the findings of the present study demonstrate that P. gingivalis 
challenge up-regulates PAR-2 mRNA expression in human GF and Jurkat T-cells. 
This enhancement of PAR-2 mRNA expression is likely to be an auto-regulatory 
effect of proteolytic activation of PAR-2 receptor on the cell membrane. Previous 
studies have confirmed that various P. gingivalis preparations induce PAR-2 
expression or activation not only in human GF (Uehara et al., 2003), but also in oral 
epithelial cells (Lourbakos et al., 2001a, Uehara et al., 2002), monocytes (Uehara et 
al., 2008a) and neutrophils (Lourbakos et al., 1998). Therefore, the inductive effect of 
P. gingivalis on PAR-2 expression is not restricted to a particular cell type and 
appears to be universal. However, the peak of PAR-2 up-regulation in the two studied 
cell types occurred at a different concentration of P. gingivalis, which was 4-fold 
greater for GF, than for Jurkat T-cells. Interestingly, beyond this concentration, PAR-
2 mRNA expression declined in both cell types, indicating that for maximal PAR-2 
induction, the optimal P. gingivalis concentration is dependent on the cell type. 
Nevertheless, despite these differences, the magnitude of PAR-2 induction was 
comparable between the two cell types. Collectively, these findings indicate that T-
cells and GF have quantitatively similar PAR-2 responses to P. gingivalis challenge, 
but the former cell type is more sensitive in this respect. This may denote that in the 
presence of lower P. gingivalis concentrations, the main source of PAR-2 induction in 
the periodontal tissues could be cells of the immune system (i.e. T-cells), whereas in 
presence of higher P. gingivalis concentrations that may cause death to T-cells, PAR-
2 expression may be compensated by the less sensitive resident connective tissue cells 
(i.e. GF). This speculation is in agreement with the capacity of P. gingivalis to evade 
and adapt to the local immune responses, as well as to establish chronic inflammation 
(Lamont and Jenkinson, 1998, Dixon and Darveau, 2005, Kishimoto et al., 2006). 
The present work also investigated if the cysteine proteases are the virulence 
factor responsible for PAR-2 induction by P. gingivalis in Jurkat T-cells. Heat-
inactivation of the P. gingivalis culture supernatant resulted in total abolishment of its 
capacity to induce PAR-2 expression in the cells. This indicates that the responsible 
component is proteinaceous and minimises the possibility that the heat-stable LPS is 
involved. Important proteinaceous virulence factors of P. gingivalis are its gingipains. 
As they also possess proteolytic activity, it is tempting to postulate that they may be 
involved in PAR-2 induction. Indeed, treatment of P. gingivalis with TLCK, a 
chemical inhibitor of cysteine proteases, prior to addition to the cells resulted in total 
abolishment of PAR-2 induction. This is in line with a recent study in gingival 
epithelial cells, demonstrating that TLCK-treatment of P. gingivalis culture 
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supernatants diminished PAR-2 expression (Dommisch et al., 2007). Therefore, it can 
be deduced that gingipains could be the virulence factor responsible for PAR-2 
induction by P. gingivalis. Previous studies have indicated that both Arg-X and Lys-X 
gingipains can activate PAR-2 (Dommisch et al., 2007, Uehara et al., 2008), but the 
former are more efficient in this respect (Giacaman et al., 2007, Yun et al., 2007). 
Nevertheless, their combined action is considered to more efficiently activate PAR-2 
(Chung et al., 2004, Uehara et al., 2008). 
 
5. Conclusions 
The present study demonstrated that P. gingivalis enhances PAR-2 mRNA expression 
in GF and Jurkat T-cells. GF respond at higher P. gingivalis concentrations, although 
the magnitude of the response is similar to that of Jurkat T-cells. The virulence factors 
responsible for this induction are likely to be the gingipains. This induction of PAR-2 
expression may play a role in the establishment of periodontal inflammation, as its 
activation can lead to the production of mediators of inflammation and bone 
destruction (Holzhausen et al., 2005b). To this extent, in vivo studies demonstrate that 
PAR-2-deficient mice exhibit reduced alveolar bone loss in a P. gingivalis-induced 
periodontitis model (Holzhausen et al., 2006), whereas topical application of a PAR-2 
agonist in a rat model results in exacerbation of alveolar bone loss and gingival 
inflammation (Holzhausen et al., 2005a). These findings demonstrate a role of PAR-2 
in periodontal disease, but also hold a good promise that PAR-2 might represent a 
potential target for future drug strategies. 
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Figure Legends 
 
Figure 1. Regulation of PAR-2 mRNA expression in GF by P. gingivalis. Cells were 
challenged with ascending protein concentrations of P. gingivalis culture supernatants 
for 6 h. The mRNA expression levels of PAR-2 were measured by quantitative real-
time PCR, normalized against the expression levels of 18S rRNA. The results are 
expressed as the 2-∆Ct formula. Bars represent mean values ± SEM from four 
independent experiments in four GF cell lines. The asterisks indicate statistically 
significant difference compared to the control group. 
 
Figure 2. Regulation of PAR-2 mRNA expression in Jurkat T-cells by P. gingivalis. 
Cells were challenged with ascending protein concentrations of P. gingivalis culture 
supernatants for 6 h. The mRNA expression levels of PAR-2 were measured by 
quantitative real-time PCR, normalized against the expression levels of 18S rRNA. 
The results are expressed as the 2-∆Ct formula. Bars represent mean values ± SEM 
from four independent experiments with Jurkat T-cells. The asterisk indicates 
statistically significant difference compared to the control group. 
 
Figure 3. Role of cysteine proteases and proteinaceous components in PAR-2 
regulation by P. gingivalis. Jurkat T-cells were cultured for 6 h in the absence or 
presence of un-treated, heat-inactivated, or TLCK-treated P. gingivalis culture 
supernatant (3.125 µg/ml). The mRNA expression levels of PAR-2 were measured by 
quantitative real-time PCR, normalized against the expression levels of 18S rRNA. 
The results are expressed as the 2-∆Ct formula. Bars represent mean values ± SEM 
from four independent experiments with Jurkat T-cells. The asterisk indicates 
statistically significant difference compared to the control group. 
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